Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA new revision entry, v3.6.5, was added to the study history, indicating the record was updated after the previous revision (v3.6.4). This reflects a metadata update to the record rather than substantive trial information.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history shows a new revision entry v3.6.4 was added. The previous revision v3.6.3 was removed, updating the record history to reflect the latest release.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history and the previous entry v3.6.2 was removed, updating the displayed version history.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous v3.6.0 entry was removed. This updates the page's version history without changing the underlying study information.SummaryDifference0.1%

- Check66 days agoChange DetectedEnrollment is now closed to new participants, and the history shows a new revision (v3.6.0) was added while the previous revision (v3.5.5) was removed.SummaryDifference0.2%

- Check73 days agoChange DetectedA new revision entry (v3.5.5) was added to the history, updating the record's version list. The previous revision (v3.5.4) was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.